Cargando…
SEOM clinical guidelines for the treatment of head and neck cancer (2020)
Head and neck cancers (HNC) are defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence obtained since 2017 publication, the Spanish Soc...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057973/ https://www.ncbi.nlm.nih.gov/pubmed/33635468 http://dx.doi.org/10.1007/s12094-020-02533-1 |
_version_ | 1783680935621820416 |
---|---|
author | Mesia, R. Iglesias, L. Lambea, J. Martínez-Trufero, J. Soria, A. Taberna, M. Trigo, J. Chaves, M. García-Castaño, A. Cruz, J. |
author_facet | Mesia, R. Iglesias, L. Lambea, J. Martínez-Trufero, J. Soria, A. Taberna, M. Trigo, J. Chaves, M. García-Castaño, A. Cruz, J. |
author_sort | Mesia, R. |
collection | PubMed |
description | Head and neck cancers (HNC) are defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence obtained since 2017 publication, the Spanish Society of Medical Oncology (SEOM) presents an update of the squamous cell HNC diagnosis and treatment guideline. Most relevant diagnostic and therapeutic changes from the last guideline have been updated: introduction of sentinel node biopsy in early oral/oropharyngeal cancer treated with surgery, concomitant radiotherapy with weekly cisplatin 40 mg/m(2) in the adjuvant setting, new approaches for HPV-related oropharyngeal cancer and new treatments with immune-checkpoint inhibitors in recurrent/metastatic disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12094-020-02533-1. |
format | Online Article Text |
id | pubmed-8057973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-80579732021-05-05 SEOM clinical guidelines for the treatment of head and neck cancer (2020) Mesia, R. Iglesias, L. Lambea, J. Martínez-Trufero, J. Soria, A. Taberna, M. Trigo, J. Chaves, M. García-Castaño, A. Cruz, J. Clin Transl Oncol Clinical Guides in Oncology Head and neck cancers (HNC) are defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence obtained since 2017 publication, the Spanish Society of Medical Oncology (SEOM) presents an update of the squamous cell HNC diagnosis and treatment guideline. Most relevant diagnostic and therapeutic changes from the last guideline have been updated: introduction of sentinel node biopsy in early oral/oropharyngeal cancer treated with surgery, concomitant radiotherapy with weekly cisplatin 40 mg/m(2) in the adjuvant setting, new approaches for HPV-related oropharyngeal cancer and new treatments with immune-checkpoint inhibitors in recurrent/metastatic disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12094-020-02533-1. Springer International Publishing 2021-02-26 2021 /pmc/articles/PMC8057973/ /pubmed/33635468 http://dx.doi.org/10.1007/s12094-020-02533-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Clinical Guides in Oncology Mesia, R. Iglesias, L. Lambea, J. Martínez-Trufero, J. Soria, A. Taberna, M. Trigo, J. Chaves, M. García-Castaño, A. Cruz, J. SEOM clinical guidelines for the treatment of head and neck cancer (2020) |
title | SEOM clinical guidelines for the treatment of head and neck cancer (2020) |
title_full | SEOM clinical guidelines for the treatment of head and neck cancer (2020) |
title_fullStr | SEOM clinical guidelines for the treatment of head and neck cancer (2020) |
title_full_unstemmed | SEOM clinical guidelines for the treatment of head and neck cancer (2020) |
title_short | SEOM clinical guidelines for the treatment of head and neck cancer (2020) |
title_sort | seom clinical guidelines for the treatment of head and neck cancer (2020) |
topic | Clinical Guides in Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057973/ https://www.ncbi.nlm.nih.gov/pubmed/33635468 http://dx.doi.org/10.1007/s12094-020-02533-1 |
work_keys_str_mv | AT mesiar seomclinicalguidelinesforthetreatmentofheadandneckcancer2020 AT iglesiasl seomclinicalguidelinesforthetreatmentofheadandneckcancer2020 AT lambeaj seomclinicalguidelinesforthetreatmentofheadandneckcancer2020 AT martineztruferoj seomclinicalguidelinesforthetreatmentofheadandneckcancer2020 AT soriaa seomclinicalguidelinesforthetreatmentofheadandneckcancer2020 AT tabernam seomclinicalguidelinesforthetreatmentofheadandneckcancer2020 AT trigoj seomclinicalguidelinesforthetreatmentofheadandneckcancer2020 AT chavesm seomclinicalguidelinesforthetreatmentofheadandneckcancer2020 AT garciacastanoa seomclinicalguidelinesforthetreatmentofheadandneckcancer2020 AT cruzj seomclinicalguidelinesforthetreatmentofheadandneckcancer2020 |